Home
FDA Calendar
About & More
Testimonials
Useful Links
Our Disclaimer
Updates and Roadmap
Contribute
Create Company Profile
Create Drug Profile
Browse
Contact
FDA Calendar for MELA Sciences, Inc. (MELA)
Login Now
|
Register (free)
MELA Sciences, Inc., formerly Electro-Optical Sciences, Inc., is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor’s office) instrument to assist in the early diagnosis of melanoma. The Company’s product MelaFind, features a hand-held imaging device, which emits of light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. The data are then analyzed utilizing image processing classification algorithms, trained on the database of melanomas and benign lesions, to provide information to assist in the management of the patient, including information useful in the decision of whether to biopsy the lesion.
Around The Net
Latest News
Twitter Stream
Yahoo Message Board
Google Message Board
You are reading news provided by a variety of web sources.
Trade Ideas: AONE, MELA, MOBI, SOL
5 day(s)
Big-Cap Technology Buy Signals
5 day(s)
GTXI, MELA, UBNT, PRGS Among Charts to Watch
5 day(s)
Indices Recover to Close Well Off Lows
5 day(s)
Top 10 Best-Rated Medical Equipment Stocks: KH, EC...
6 day(s)
Drug Pipeline
Drug Name
Type Of Drug
FDA Status
Drug Phase
MelaFind
Other
Unknown
Phase 3
Events
No future events listed at this time, please check back later.
2 past event(s) found.
Click here
to view them.
Outcome
Past Events
MELA Sciences, Inc.
08/26/2010
Past Event
FDA Panel Review:
FDA panel review
(relates to the drug
MelaFind
)
MELA Sciences, Inc.
11/18/2010
Past Event
FDA Panel Review:
FDA panel review of MelaFind
(relates to the drug
MelaFind
)
Add New Event
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Event
Important Links
No links found.
Add New Link
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Link
MELA
$4.48
0.04 +0.90%
2/3/2012 3:59:00 PM
Sponsors
Other Links
Corporate Website
Analyst Estimates (MarketWatch)
CNN Money
Google Finance
Guru Focus
Major Holders
MSN Money
SEC Filings (EDGAR Online)
Seeking Alpha
Yahoo! Finance